Matches in Nanopublications for { ?s ?p "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_assertion description "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_provenance.
- NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_assertion description "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_provenance.
- assertion description "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_assertion description "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_provenance.